RxDoctor Payments Data

Rohit Khanna, MD

Psychiatry · Marietta, GANPI 1225144140

Payments from drug & device makers

$1,557in general payments, 2019–2025

Across 82 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$416
  • Otsuka America Pharmaceutical, Inc.$350
  • Indivior Inc.$181
  • Teva Pharmaceuticals USA, Inc.$164
  • Alkermes, Inc.$102
  • AbbVie$74
  • plus $270 from 7 others

What the payments were for

  • Food & beverage$1,557100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,557 in reported general payments places this provider in the 70th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$217,404
Medicare patients
156
Services billed
2,361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine32$253,481
Invega SustennaPaliperidone Palmitate22$49,562
Lurasidone Hcl13$11,922
TrintellixVortioxetine Hydrobromide22$10,400
Aripiprazole82$4,683
Atomoxetine Hcl46$3,620
Quetiapine Fumarate109$2,865
Asenapine Maleate11$2,560
Alprazolam350$2,205
Clozapine17$1,633
Venlafaxine Hcl ErVenlafaxine Hcl86$1,484
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine74$1,482
Oxcarbazepine37$1,403
Duloxetine Hcl98$1,374
Clonazepam240$1,188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$164$253,48132 claims
Johnson & JohnsonInvega Sustenna$416$49,56222 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$52$10,40022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →